Ameritas Investment Partners, Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 119 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$173,612
-1.7%
3,775
+22.8%
0.01%0.0%
Q2 2023$176,605
+53.3%
3,0730.0%0.01%
+40.0%
Q1 2023$115,238
+23.4%
3,0730.0%0.01%
+25.0%
Q4 2022$93,358
+8.6%
3,0730.0%0.00%0.0%
Q3 2022$86,000
-18.9%
3,0730.0%0.00%
-20.0%
Q2 2022$106,000
-3.6%
3,0730.0%0.01%
+25.0%
Q1 2022$110,000
+52.8%
3,0730.0%0.00%
+100.0%
Q4 2021$72,000
+24.1%
3,0730.0%0.00%0.0%
Q3 2021$58,000
-6.5%
3,0730.0%0.00%0.0%
Q2 2021$62,000
+10.7%
3,0730.0%0.00%0.0%
Q1 2021$56,000
-9.7%
3,0730.0%0.00%
-33.3%
Q4 2020$62,000
+6.9%
3,0730.0%0.00%0.0%
Q3 2020$58,000
-15.9%
3,0730.0%0.00%0.0%
Q2 2020$69,000
+50.0%
3,0730.0%0.00%0.0%
Q1 2020$46,000
-22.0%
3,0730.0%0.00%0.0%
Q4 2019$59,000
-3.3%
3,0730.0%0.00%0.0%
Q3 2019$61,000
-6.2%
3,0730.0%0.00%0.0%
Q2 2019$65,000
+3.2%
3,0730.0%0.00%0.0%
Q1 2019$63,000
+3.3%
3,0730.0%0.00%0.0%
Q4 2018$61,000
+3.4%
3,0730.0%0.00%0.0%
Q3 2018$59,000
+25.5%
3,0730.0%0.00%
+50.0%
Q2 2018$47,000
-19.0%
3,0730.0%0.00%
-33.3%
Q1 2018$58,000
-1.7%
3,0730.0%0.00%0.0%
Q4 2017$59,000
+20.4%
3,0730.0%0.00%
+50.0%
Q3 2017$49,000
-10.9%
3,0730.0%0.00%
-33.3%
Q2 2017$55,000
+22.2%
3,0730.0%0.00%
+50.0%
Q1 2017$45,0003,0730.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders